NYSE · CIK 0000352915
UHS UNIVERSAL HEALTH SERVICES INC
Insider trading from SEC Form 4. Last filing Dec 12, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at UNIVERSAL HEALTH SERVICES INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 19Weak | sell | Singer Maria Ruderman director | $309k | 1,614 | -22% | - |
Congressional trades
2 trades in UHS disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Alan Armstrong Senate · R-OK | Purchase | UHS Universal Health Services, Inc. Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Julia Letlow House · R-LA | Purchase | UHS Universal Health Services, Inc. Common Stock | $1,001 to $15k | Oct 23, 2025 | 82 days after the trade |
Transactions
The last 5 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Singer Maria Ruderman director | MOption exercise Class B Common Stock | +5,000 | $67.69 | $338k | 9,265 | Dec 12, 2024 |
| Dec 11, 2024 | Singer Maria Ruderman director | FTax withholding Class B Common Stock | -886 | $191.19 | $169k | 8,379 | Dec 12, 2024 |
| Dec 11, 2024 | Singer Maria Ruderman director | FTax withholding Class B Common Stock | -886 | $191.15 | $169k | 7,493 | Dec 12, 2024 |
| Dec 11, 2024 | Singer Maria Ruderman director | SOpen-market sale Class B Common Stock | -1,614 | $191.15 | $309k | 5,879 | Dec 12, 2024 |
| Dec 11, 2024 | Singer Maria Ruderman director | MOption exercise Option To Purchase Class B Common Stockderivative | -5,000 | $0.00 | $0 | 5,000 | Dec 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.